Effect of esketamine nasal spray on cognition in patients with treatment-resistant depression: results from five phase-3 studies

被引：0

作者：

Morrison, R. ^{[1
]}

Singh, J. ^{[2
]}

Daly, E. ^{[3
]}

Fedgchin, M. ^{[4
]}

Wajs, E. ^{[5
]}

Alusio, L. ^{[2
]}

Ochs-Ross, R. ^{[4
]}

Popova, V. ^{[5
]}

Karcher, K. ^{[6
]}

Lane, R. ^{[6
]}

Lim, P. ^{[6
]}

Cooper, K. ^{[7
]}

Maruff, P. ^{[8
]}

Hough, D. ^{[4
]}

Drevets, W. ^{[2
]}

Manji, H. ^{[4
]}

机构：

[1] Janssen Res & Dev LLC, Neurosci Integrat Solut, Titusville, NJ USA

[2] Janssen Res & Dev, Cent Nervous Sys, San Diego, CA USA

[3] Janssen Pharmaceut, Mood Disorders, Titusville, NJ USA

[4] Janssen Res & Dev, Cent Nervous Sys, Titusville, NJ USA

[5] Janssen Res & Dev, Cent Nervous Sys, Beerse, Belgium

[6] Janssen Res & Dev, Clin Biostats, Titusville, NJ USA

[7] Janssen Res & Dev LLC, Clin Biostats, Spring House, PA USA

[8] Cogstate Ltd, Neuropsychol, Melbourne, Vic, Australia

来源：

关键词：

D O I：

10.1016/j.euroneuro.2019.09.104

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P.038

引用

页码：S47 / S48

页数：2